Cagrilintide — anyone running it and what outcomes

C
Joined 2026
21 posts
cagrisemaMember
2/28/2026 · 1823 views

Cagri is underused in the GLP-1 conversation. Amylin analog, weekly dosing, pairs with sema or standalone. What doses and outcomes are people seeing?

8 Replies

S
Joined 2026
33 posts
3/1/2026

Ran cagri 2.4mg weekly for 12 weeks. -4.8kg, slow and steady. Different feel than GLP-1 — less nausea, more satiety after meals, slower gastric emptying is noticeable.

Week 14
  • Semaglutide · 1.7 mg · weekly · sub-Q
T
Joined 2026
50 posts
3/2/2026

Cagri alone at 2.4mg is ~60% of GLP-1 mono-efficacy in my observation. The combo with sema is where cagri earns its keep.

Tirze cycle
  • Tirzepatide · 5 mg · weekly · sub-Q
G
Joined 2026
40 posts
3/4/2026

Cagri's mechanism (amylin) is complementary to GLP-1. Combined therapy has shown additive effects in trials. Worth the extra compound if you're hitting a GLP-1 plateau.

M
Joined 2026
36 posts
3/4/2026

Haven't tried. Keeping an eye on the combo data from the sema/cagri trials.

F
Joined 2026
30 posts
3/5/2026

Cagri + sema combo at low doses was smoother than sema up-titrated alone for me. Less nausea per kg lost. Worth considering if sema side effects are the blocker.

S
Joined 2026
40 posts
slow_loseMember
3/7/2026

Ran cagri alone for 16 weeks, -6.1kg. Slow but extremely tolerable. For people who can't handle GLP-1 nausea, this is the option.

F
Joined 2026
22 posts
4/22/2026

Cagri solo is honestly kinda weak if you've got any tolerance to GLP-1s already. The amylin angle is real but it's not a replacement, it's an add-on. If you're looking to break through a plateau the combo makes sense, but don't sleep on just pushing sema dose higher first. Seen way more people get solid results that way than introducing another compound into the mix.

P
Joined 2026
50 posts
19d ago

yeah cagri solo felt like spinning wheels for me. stacked it with low dose sema and thats when shit actually moved. the combo thing is legit if youre already familiar with glp-1 sides

Sign in to reply.